Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Current evidence relies mostly on laboratory and animal studies, while controlled human data remains limited
GLP-1 receptor agonists function by: Stimulating insulin release when blood sugar levels are high Reducing glucagon secretion, which helps lower blood sugar Slowing gastric emptying, leading to increased satiety Affecting appetite centers in the brain, reducing food intake While these mechanisms contribute to the drugs effectiveness, they may also play a role in potential side effects, including the rare but serious risk of NAION
Your body prioritizes vital organ function over salivary gland output
This therapeutic strategy has been validated across various platforms, including in vitro studies, mouse models, and GBM organoids derived from patient tumor samples [162]
Conventional treatments for chemotherapy-associated nephrotoxicity
